Doctor'S Life Sciences (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 02-01-2025
- Paid Up Capital ₹ 2.50 Cr
as on 02-01-2025
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 33.00 Cr
as on 02-01-2025
- Revenue 5.04%
(FY 2023)
- Profit 7.01%
(FY 2023)
- Ebitda 3540.35%
(FY 2023)
- Net Worth 5.20%
(FY 2023)
- Total Assets 14.04%
(FY 2023)
About Doctor'S Life Sciences (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹33.00 Cr.
Chandrasekhar Jonna, Chalamaiah Thulabandula, and Sree Tulabandula serve as directors at the Company.
- CIN/LLPIN
U85100AP2007PLC054466
- Company No.
054466
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Jun 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Nellore, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Doctor'S Life Sciences (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrasekhar Jonna  | Director | 15-Jun-2007 | Current |
| Chalamaiah Thulabandula | Director | 15-Jun-2007 | Current |
| Sree Tulabandula | Director | 15-Jun-2007 | Current |
Financial Performance of Doctor'S Life Sciences (India).
Doctor'S Life Sciences (India) Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.04% increase. The company also saw a slight improvement in profitability, with a 7.01% increase in profit. The company's net worth moved up by a moderate rise of 5.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Doctor'S Life Sciences (India)?
In 2023, Doctor'S Life Sciences (India) had a promoter holding of 47.99% and a public holding of 52.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Doctors' Vet-Pharma Private LimitedActive 24 years 1 monthChalamaiah Thulabandula and Sree Tulabandula are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Mar 2024 | ₹2.00 Cr | Open |
State Bank Of India Creation Date: 20 Feb 2020 | ₹19.65 Cr | Open |
State Bank Of India Creation Date: 16 Mar 2015 | ₹3.50 Cr | Open |
How Many Employees Work at Doctor'S Life Sciences (India)?
Doctor'S Life Sciences (India) has a workforce of 76 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Doctor'S Life Sciences (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doctor'S Life Sciences (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
